The AD/PD™ Alzheimer’s disease and Parkinson’s disease Conference will take place between 1-5 April in Vienna, Austria. The conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
Among the many highlights, two oral presentations featuring EPAD data will be presented.
- Symposium “WHITE MATTER ALTERATIONS AND MRI” Tuesday, 01.04.2025, 10:45 – 12:45, Room Hall A Oral talk “Polygenic Pathways Shape White Matter Vulnerability To Alzheimer’s Disease Pathology” by Mario Tranfa (10:45-11:00)
- Symposium “MRI” Tuesday, 04.04.2025, 16:20 – 18:20, Room Hall E
Oral talk “AI-Driven Classification Of Alzheimer’s Disease And Frontotemporal Dementia From Magnetic Resonance Imaging” by Robin Wolz (17:05-17:20)
EPAD offers a way of accessing the data, samples and image data collected during the EPAD Longitudinal Cohort Study to academic researchers, institutions and companies from all over the world. This is shared through secure online Workspaces via the Alzheimer’s Disease Workbench.
For more information about the conference and the EPAD project, please visit AD/PD 2025 and EPAD’s website, respectively.
